Zobrazeno 1 - 4 of 4 pro vyhledávání: '"Lorenzo Anasagasti-Angulo"'
1
HeberFERON, formulation based on IFNs alpha2b and gamma for the treatment of non-melanoma skin cancer
Autor: Carmen Valenzuela Silva, Yoddali Ballester Caballero, Yaquelin Duncan Roberts, Lorenzo Anasagasti Angulo, Yanelda Garcia Vega, Jorge Marin Guerra, Katherine Batista, Ángela D. Tuero Iglesias, Edgar Tijerino Arrieta, Yanisel Jiménez Barbán, Leovaldo Alvarez Falcon, Iraldo Bello Rivero, Vladimir Sánchez Linares, Sonia Collazo
Publikováno v: Australasian Medical Journal, Vol 10, Iss 6, Pp 509-515 (2017)
Background Surgery remains the procedure of election for the treatment of non-melanoma skin cancer (NMSC). However, after recurrence, or under surgical complex scenarios, other therapeutic modalities have to be indicated. Immune suppression is associ
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf8b3c6e47f4d7b0a9d8abe1aa3fc06d
https://doi.org/10.21767/amj.2017.3013
Zobrazit plný text záznamu
2
Treatment of advanced, recurrent, resistant to previous treatments basal and squamous cell skin carcinomas with a synergistic formulation of interferons. Open, prospective study
Autor: Yanelda García-Vega, Lorenzo Anasagasti-Angulo, Iraldo Bello-Rivero, Silvia Barcelona-Perez, Pedro Lopez-Saura
Publikováno v: BMC Cancer
BMC Cancer, Vol 9, Iss 1, p 262 (2009)
Background Aggressive non-melanoma skin cancer (deeply infiltrating, recurrent, and morphea form lesions) are therapeutically challenging because they require considerable tissue loss and may demand radical disfiguring surgery. Interferons (IFN) may
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a72a3a08fe7001cb296a8f0fd74778c2
http://europepmc.org/articles/PMC2724551
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje